These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34034752)

  • 1. Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran.
    Sadeghi F; Cheraghian B; Mohammadi Z; Sepanlou SG; Masoudi S; Rahimi Z; Danehchin L; Paridar Y; Abolnezhadian F; Noori M; Mard SA; Shayesteh AA; Poustchi H
    Popul Health Metr; 2021 May; 19(1):26. PubMed ID: 34034752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines.
    Mahdavi M; Parsaeian M; Mohajer B; Modirian M; Ahmadi N; Yoosefi M; Mehdipour P; Djalalinia S; Rezaei N; Haghshenas R; Pazhuheian F; Madadi Z; Sabooni M; Razi F; Samiee SM; Farzadfar F
    BMC Public Health; 2020 Mar; 20(1):347. PubMed ID: 32183754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential epidemiological impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on the Chinese population: a cross-sectional study in rural areas of Liaoning Province.
    Dong Y; Sun Z; Li Z; Guo X; Sun G; Xie Y; Zheng J; Dai Y; Wang Y; Guo R; Zheng L; Sun Y
    BMJ Open; 2020 Sep; 10(9):e035900. PubMed ID: 32963064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individuals.
    Alyabsi M; Gaid R; Alqunaibet A; Alaskar A; Mahmud A; Alghamdi J
    BMJ Open; 2020 Dec; 10(12):e041973. PubMed ID: 33384395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017.
    Mirzaei M; Mirzaei M; Mirzaei M; Bagheri B
    BMC Cardiovasc Disord; 2020 Aug; 20(1):372. PubMed ID: 32799819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study.
    Sepanlou S; Najafi F; Poustchi H; Parsaeian M; Ahmadi A; Somi M; Moradpour F; Alizadeh-Navaei R; Gohari A; Zamani B; Esmaeilinadimi A; Rezaianzadeh A; Mansour-Ghanaei F; Bahramali E; Ansari-Moghaddam A; Hamzeh B; Zanganeh Yousefabadi E; Zare Sakhvidi MJ; Mohebbi I; Fattahi MR; Nejatizadeh A; Marioryad H; Motamed-Gorji N; Roozafzai F; Eghtesad S; Mohammadi Z; Shayanrad A; Sharafkhah M; Etemadi A; Kamangar F; Juraschek SP; Malekzadeh R
    Sci Rep; 2022 Mar; 12(1):4057. PubMed ID: 35260709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study.
    Barua L; Faruque M; Banik PC; Ali L
    Medicina (Kaunas); 2019 Jun; 55(7):. PubMed ID: 31248050
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.
    Hussain A; Virani SS; Zheng L; Gluckman TJ; Borden WB; Masoudi FA; Maddox TM
    J Am Heart Assoc; 2022 Jun; 11(11):e024107. PubMed ID: 35656989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline.
    Lee JH; Kim SH; Kang SH; Cho JH; Cho Y; Oh IY; Yoon CH; Lee HY; Youn TJ; Chae IH; Kim CH
    Sci Rep; 2018 Sep; 8(1):13155. PubMed ID: 30177714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline.
    Kibria GMA; Swasey K; Kc A; Mirbolouk M; Sakib MN; Sharmeen A; Chadni MJ; Stafford KA
    JAMA Netw Open; 2018 Jul; 1(3):e180606. PubMed ID: 30646022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension prevalence alteration in 92 815 nurses based on the new standard by 2017 ACC/AHA hypertension guideline: observational cross-sectional study from China.
    Zhao B; Li J; Liu J; Hao Y; Zhen Y; Feng D; Xu M; Chen X; Yang X; Zuo A; Jia R; Zhang R; Fan A; Wang Y; Yuan M; Tong L; Chen S; Cui J; Zhao M; Cui W
    BMJ Open; 2019 Aug; 9(8):e027201. PubMed ID: 31471431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
    J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Li D; Zeng X; Huang Y; Lei H; Li G; Zhang N; Huang W
    Curr Hypertens Rep; 2019 Feb; 21(3):21. PubMed ID: 30820764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated hypertension prevalence, awareness, and control rates based on the 2017ACC/AHA high blood pressure guideline.
    Zhou Y; Jia L; Lu B; Gu G; Hu H; Zhang Z; Bai L; Cui W
    J Clin Hypertens (Greenwich); 2019 Jun; 21(6):758-765. PubMed ID: 31131983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secular trends of hypertension prevalence based on 2017 ACC/AHA and 2018 Chinese hypertension guidelines: Results from CHNS data (1991-2015).
    Zheng L; Dai Y; Fu P; Yang T; Xie Y; Zheng J; Gao J; Niu T
    J Clin Hypertens (Greenwich); 2021 Jan; 23(1):28-34. PubMed ID: 32970919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
    Khera R; Lu Y; Lu J; Saxena A; Nasir K; Jiang L; Krumholz HM
    BMJ; 2018 Jul; 362():k2357. PubMed ID: 29997129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline.
    Dorans KS; Mills KT; Liu Y; He J
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them.
    Jiao Y; Sun Z; Xie Y; Zheng J; Li Z; Guo X; Dai Y; Zheng L; Sun Y
    BMC Cardiovasc Disord; 2020 May; 20(1):237. PubMed ID: 32429909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the American College of Cardiology (ACC/AHA) 2017 Guideline for the Management of Hypertension in Adults and Comparison with the 2014 Eighth Joint National Committee Guideline.
    AlAhmad M; Beiram R; AbuRuz S
    J Saudi Heart Assoc; 2021; 33(1):16-25. PubMed ID: 33936937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Determinants of Hypertension in India Based on the 2017 ACC/AHA Guideline: Evidence from the India National Family Health Survey.
    Abariga SA; Khachan H; Al Kibria GM
    Am J Hypertens; 2020 Mar; 33(3):252-260. PubMed ID: 31711220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.